These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 25828651)

  • 1. Hypersensitivity reaction during epirubicin infusion in a cat.
    Elliott J
    J Small Anim Pract; 2015 May; 56(5):356. PubMed ID: 25828651
    [No Abstract]   [Full Text] [Related]  

  • 2. Images in clinical medicine. Extravasation of epirubicin.
    Vano-Galvan S; Jaen P
    N Engl J Med; 2009 May; 360(20):2117. PubMed ID: 19439746
    [No Abstract]   [Full Text] [Related]  

  • 3. Feasibility of 21-day continuous infusion of epirubicin in hormone-refractory prostate cancer patients.
    Berruti A; Mosca A; Bitossi R; Gorzegno G; Guercio S; Poggio M; Tampellini M; Porpiglia F; Ostellino O; Scarpa RM; Dogliotti L
    Anticancer Res; 2005; 25(6C):4475-9. PubMed ID: 16334129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivery of epirubicin via slow infusion as a strategy to mitigate chemotherapy-induced cardiotoxicity.
    Yang F; Lei Q; Li L; He JC; Zeng J; Luo C; Yeung SJ; Yang R
    PLoS One; 2017; 12(11):e0188025. PubMed ID: 29131861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anaphylaxis and anaesthesia.
    Armitage-Chan E
    Vet Anaesth Analg; 2010 Jul; 37(4):306-10. PubMed ID: 20636562
    [No Abstract]   [Full Text] [Related]  

  • 6. [Promising new injection method to prevent angialgia/phlebitis from epirubicin hydrochloride therapy for breast cancer].
    Ono C; Yamagami M; Kamatani R; Yamamoto M; Mukouyama T; Sugimoto M; Suzuki T; Kamo N; Seki N; Eguchi K; Ikeda T
    Gan To Kagaku Ryoho; 2012 May; 39(5):777-81. PubMed ID: 22584330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anthracycline cardiotoxicity: one size does not fit all!
    Hershman DL; Neugut AI
    J Natl Cancer Inst; 2008 Aug; 100(15):1046-7. PubMed ID: 18664649
    [No Abstract]   [Full Text] [Related]  

  • 8. A dose-finding study of epirubicin in combination with paclitaxel in the treatment of advanced breast cancer.
    Conte PF; Michelotti A; Baldini E; Salvadori B; Gennari A; Da Prato M; Tibaldi C; Salzano E; Gentile A
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):28-31. PubMed ID: 8893896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic vasculitis with severe cutaneous manifestation as a suspected idiosyncratic hypersensitivity reaction to fenbendazole in a cat.
    Jasani S; Boag AK; Smith KC
    J Vet Intern Med; 2008; 22(3):666-70. PubMed ID: 18466245
    [No Abstract]   [Full Text] [Related]  

  • 10. [Neoadjuvant intraarterial chemotherapy with dose intensification in locally advanced breast cancer].
    Takatsuka Y; Shin E; Fukuda K; Mishima H; Tono T; Yagyuu T; Kobayashi K; Kikkawa N
    Gan To Kagaku Ryoho; 1995 Sep; 22(11):1546-8. PubMed ID: 7574755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of elevated liver function parameters on the pharmacokinetics of doxorubicin and epirubicin--a population based pharmacokinetic study of CESAR-APOH. Central European Society for Anticancer Drug Research. Working Group for Pharmacology in Oncology and Hematology.
    Müller HJ; Grubert M; Hilger R; Richly H; Port R; Scheulen M; Mross K;
    Int J Clin Pharmacol Ther; 2002 Dec; 40(12):575-7. PubMed ID: 12503820
    [No Abstract]   [Full Text] [Related]  

  • 12. A case of manic episode during treatment with 5-fluorouracil, epirubicin and cyclophosphamide for breast cancer.
    Pacchiarotti I; Mazzarini L; Pellegrini P; Venturelli V; Sani G; Sánchez-Moreno J; Mancinelli I; Tatarelli R; Kotzalidis GD; Girardi P
    Gen Hosp Psychiatry; 2007; 29(5):461-3. PubMed ID: 17888816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Change of formulation decreases venous irritation in breast cancer patients receiving epirubicin.
    Nagata K; Egashira N; Yamada T; Watanabe H; Yamauchi Y; Oishi R
    Support Care Cancer; 2012 May; 20(5):951-5. PubMed ID: 21519948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic arterial infusion chemotherapy with epirubicin in patients with advanced hepatocellular carcinoma and portal vein tumor thrombosis.
    Ikeda M; Okusaka T; Ueno H; Morizane C; Iwasa S; Hagihara A; Kojima Y
    Oncology; 2007; 72(3-4):188-93. PubMed ID: 18097170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Results of clinical study with epirubicin hydrochloride injectable solution in hepatoma].
    Monden M; Nakamura H; Yayoi E; Monden T; Ohi H; Arisawa J; Masuzawa M; Shimizu T; Tomono N; Seki K; Nakao N; Todo A; Inoue Y; Sakon M; Ohsaki Y; Hosoki T
    Gan To Kagaku Ryoho; 1998 Sep; 25(11):1713-9. PubMed ID: 9757197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of epirubicin-based chemotherapy and dexrazoxane supplementation on QT dispersion in non-Hodgkin lymphoma patients.
    Galetta F; Franzoni F; Cervetti G; Cecconi N; Carpi A; Petrini M; Santoro G
    Biomed Pharmacother; 2005 Dec; 59(10):541-4. PubMed ID: 16325366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A clinical trial of neoadjuvant intraarterial chemotherapy for the treatment of locally advanced breast cancer].
    Takatsuka Y; Shin E; Kikkawa N
    Gan To Kagaku Ryoho; 1996 Sep; 23(11):1523-5. PubMed ID: 8854796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug eruption due to intravesical instillations of both epirubicin and mitomycin C.
    Okumura A; Oishi N; Kaji K; Imamura T; Fuse H
    J Dermatol; 2009 Jul; 36(7):419-22. PubMed ID: 19583691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased dosage of epirubicin and mitomycin-C for the treatment of metastatic adenocarcinoma of unknown primary site.
    Polyzos A; Koulentianos E; Tzianoumis L; Sfikakis P
    J Chemother; 1989 Jul; 1(4 Suppl):1185-6. PubMed ID: 16312826
    [No Abstract]   [Full Text] [Related]  

  • 20. Serious allergic reaction to administration of epirubicin.
    Oltmans R; van der Vegt SG
    Neth J Med; 2003 Jun; 61(6):226-7. PubMed ID: 12948166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.